Department of Gastroenterology, Çukurova University, Adana, Turkey.
Turk J Gastroenterol. 2023 Mar;34(3):262-269. doi: 10.5152/tjg.2023.21791.
Hepatocellular carcinoma mostly develops in a cirrhotic (80%) background. The clinical features of cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma also differ. We aimed to determine the clinicopathologic features, tumor characteristics, treatment options, and overall survival after diagnosing hepatocellular carcinoma and prognostic factors effective on survival of hepatocellular carcinoma developing in cirrhotic and non-cirrhotic conditions.
In our study, 220 patients aged over 18 years who were histologically diagnosed as having hepatocellular carcinoma were included. The patients were divided into 2 groups as cirrhotic and non-cirrhotic.
When the tumor morphologies were examined in our study, it was observed that they were mostly solitary in both groups. Cirrhotic hepatocellular carcinomas had significantly higher rates of invasion than the non-cirrhotic group (35.3% vs. 20.3%, respectively) (P <.05). The survival rate was found to be better in the non-cirrhotic group (17.5 months vs. 11.5 months) (P <.05). Age, maximal tumor diameter, and morphologically infiltrative tumor character were found to be independent risk factors affecting survival in patients with cirrhosis. Portal vein invasion, alfa-fetoprotein, and the absence of an underlying risk factor in the etiology were observed as independent risk factors affecting survival in patients with non-cirrhosis.
Cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma had different clinicopathologic features and risk factors. We analyzed that treatment choice trends were different between the 2 groups. We also observed that the factors that affected survival were different between the 2 groups.
肝细胞癌主要在肝硬化(80%)背景下发生。肝硬化性肝细胞癌和非肝硬化性肝细胞癌的临床特征也不同。我们旨在确定诊断肝细胞癌后的临床病理特征、肿瘤特征、治疗选择以及总生存率,以及肝硬化和非肝硬化条件下发生的肝细胞癌的生存预后因素。
在我们的研究中,纳入了 220 名年龄在 18 岁以上且组织学诊断为肝细胞癌的患者。这些患者被分为肝硬化组和非肝硬化组。
在我们的研究中,当检查肿瘤形态时,观察到两组肿瘤大多为单发。肝硬化性肝细胞癌的浸润率明显高于非肝硬化组(分别为 35.3%和 20.3%)(P<.05)。非肝硬化组的生存率更好(17.5 个月比 11.5 个月)(P<.05)。年龄、最大肿瘤直径和形态浸润性肿瘤特征被发现是影响肝硬化患者生存的独立危险因素。门静脉侵犯、甲胎蛋白和病因中无潜在危险因素被认为是影响非肝硬化患者生存的独立危险因素。
肝硬化性肝细胞癌和非肝硬化性肝细胞癌具有不同的临床病理特征和危险因素。我们分析了两组之间的治疗选择趋势不同。我们还观察到两组之间影响生存的因素不同。